ArticleScientific reports2025
Distinct protein profiles in cord blood plasma of children with autism spectrum disorder.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal Extracellular Vesicles During Pregnancy and Autism Risk in Children.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) has a genetic origin in approximately 30% of cases, while the remaining causes are primarily linked to epigenetic and non-genetic factors. This study aims to identify potential non-genetic causes contributing to ASD by investigating the underlying cellular mechanisms through proteomic analysis. Extracellular vesicles (EVs) mediate cellular communication and are linked to brain development disorders. Here, we utilize mass-spectrometry-based proteomic analysis of EVs derived from umbilical cord blood plasma collected from 30 children diagnosed with non-syndromic ASD and 30 neurotypical controls. The analysis identified 565 proteins with significantly different expression levels, most of which were more abundant in the ASD group. Notably, the protein expression variances were markedly lower in the ASD group, suggesting a similar cellular activity. Differentially expressed proteins were clustered using String software into 3 groups: mitochondria, endoplasmic reticulum (ER), and a mixture of immune and cytoskeletal proteins. Further statistical analysis identified 11 strongly predictive ASD proteins, while the Human Protein Atlas recognized an additional 13 brain-specific proteins. A portion of these 24 proteins was associated with synaptogenesis and myelination. These findings suggest that, despite diverse etiologies, ASD may converge on a common final pathway involving mitochondrial and ER dysfunction, resulting in abnormal synaptogenesis. This study presents the first unbiased proteomic analysis of exosomal proteins aimed at determining whether neurodevelopmental disruptions linked to ASD originate prenatally or postnatally.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.